Medical Journals

Steatosis As a Risk Factor in Liver Surgery.

Authors:
  • Veteläinen Reeta
  • van Vliet Arlène
  • Gouma Dirk J
  • van Gulik Thomas M

From: Department of Surgery, University of Amsterdam, Amsterdam, The Netherlands.

Annals of surgery

  • Publish Date: Jan 2007
  • ISSN: 0003-4932
  • Volume: 245
  • Issue: 1
  • Pages: 20-30
  • Medium: Print
  • Language: English
  • Citation (JAMA): Veteläinen Reeta, van Vliet Arlène, Gouma Dirk J, et al. Steatosis As a Risk Factor in Liver Surgery.. Ann. Surg. Jan 2007;245:20-30

Abstract

OBJECTIVE: To review present knowledge of the influence of hepatic steatosis in liver surgery as derived from experimental and clinical studies. SUMMARY BACKGROUND DATA: Hepatic steatosis is the most common chronic liver disease in the Western world, and it is associated with obesity, diabetes, and metabolic syndrome. Fatty accumulation affects hepatocyte homeostasis and potentially impairs recovery of steatotic livers after resection. This is reflected clinically in increased mortality and morbidity after liver resection in patients with any grade of steatosis. Because of the epidemic increase of obesity, hepatic steatosis will play an even more significant role in liver surgery. METHODS: A literature review was performed using MEDLINE and key words related to experimental and clinical studies concerning steatosis. RESULTS: Experimental studies show the increased vulnerability of steatotic livers to various insults, attributed to underlying metabolic and pathologic derangements induced by fatty accumulation. In clinical studies, the severity of steatosis has an important impact on patient outcome and mortality. Even the mildest form of steatosis increases the risk of postoperative complications. CONCLUSIONS: Hepatic steatosis is a major factor determining patient outcome after surgery. Further research is needed to clarify the clinical relevance of all forms and severity grades of steatosis for patient outcome. Standardized grading and diagnostic methods need to be used in future clinical trials to be able to compare outcomes of different studies.

Mesh Headings (Keywords): Fatty Liver, Hepatectomy, Humans, Risk Factors, Treatment Outcome


Check for Full Text / PubMed Unique Identifier (PMID): 17197961


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.